Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
13.69
-0.22 (-1.58%)
May 25, 2022 4:30 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.12 | 14.58 | 0 | 20.16 | 0 | 0 | 0 |
| Revenue Growth (YoY) | -92.32% | - | - | - | - | - | - |
| Gross Profit | 1.12 | 14.58 | 0 | 20.16 | 0 | 0 | 0 |
| Selling, General & Admin | 18.51 | 2.12 | 9.76 | 13.49 | 9.24 | 5.27 | 0.02 |
| Research & Development | 19.67 | 15.01 | 12.82 | 17.85 | 12.15 | 11.37 | 0 |
| Other Operating Expenses | 74.16 | 0 | 1.86 | 0 | 0 | 0 | 0 |
| Operating Expenses | 112.34 | 17.13 | 24.44 | 31.34 | 21.39 | 16.63 | 0.02 |
| Operating Income | -111.22 | -2.55 | -24.44 | -11.18 | -21.39 | -16.63 | -0.02 |
| Interest Expense / Income | 0.67 | 0.82 | 0 | 0 | 0.11 | 0.48 | 0.01 |
| Other Expense / Income | -1.79 | 0.11 | -1.17 | -0.78 | -0.09 | -0.13 | 0 |
| Pretax Income | -110.09 | -3.48 | -23.27 | -10.4 | -21.4 | -16.98 | -0.03 |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -110.09 | -3.48 | -23.27 | -10.4 | -21.4 | -16.98 | -0.03 |
| Preferred Dividends | 0.65 | 0.99 | 0 | 0 | 0.94 | 3.93 | 0 |
| Net Income Common | -110.74 | -4.47 | -23.27 | -10.4 | -22.34 | -20.91 | -0.03 |
| Shares Outstanding (Basic) | 9 | 3 | 3 | 2 | 1 | 0 | 0 |
| Shares Outstanding (Diluted) | 9 | 3 | 3 | 2 | 1 | 0 | 0 |
| Shares Change | 250.99% | -6.04% | 19.62% | 56.56% | 2441.82% | -82.95% | - |
| EPS (Basic) | -12.41 | -1.76 | -8.55 | -4.65 | -15.45 | -367.80 | -0.15 |
| EPS (Diluted) | -12.41 | -1.76 | -8.55 | -4.65 | -15.45 | -367.80 | -0.15 |
| Free Cash Flow Per Share | -2.52 | -5.00 | -8.90 | -2.58 | -13.07 | -278.50 | -0.07 |
| Gross Margin | 100.00% | 100.00% | - | 100.00% | - | - | - |
| Operating Margin | -9930.09% | -17.48% | - | -55.47% | - | - | - |
| Profit Margin | -9829.46% | -23.85% | - | -51.58% | - | - | - |
| Free Cash Flow Margin | -2006.16% | -87.11% | - | -29.00% | - | - | - |
| Effective Tax Rate | -0.00% | -0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA | -109.15 | -2.49 | -23.19 | -10.35 | -21.24 | -16.43 | -0.02 |
| EBITDA Margin | -9745.27% | -17.04% | - | -51.35% | - | - | - |
| EBIT | -109.42 | -2.66 | -23.27 | -10.4 | -21.29 | -16.5 | -0.02 |
| EBIT Margin | -9769.91% | -18.25% | - | -51.58% | - | - | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).